Company Overview of MyoKardia, Inc.
MyoKardia, Inc. develops a pipeline of small molecule therapeutics that address key clinical needs for patients with genetic heart disease. The company was founded in 2012 and is based in San Francisco, California.
455 Mission Bay Boulevard South
San Francisco, CA 94158
Founded in 2012
Key Executives for MyoKardia, Inc.
MyoKardia, Inc. Key Developments
Similar Private Companies By Industry
|SCOLR, Inc., Probiotics Development and Manufacturing Business||United States|
|Firma Medical, LLC||United States|
|Aventis Bio-Services Inc.||United States|
|Targeted Cell Therapies LLC||United States|
|Teva Women's Health, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- Philadelphia, PA | PwCPosted: Apr 09
- Missouri | AstellasPosted: Feb 21
Sponsored Financial Commentaries
To contact MyoKardia, Inc., please visit www.myokardia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.